SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants
Rotondo, J.C.; Martini, F.; Maritati, M.; Mazziotta, C.; Di Mauro, G.; Lanzillotti, C.; Barp, N.; Gallerani, A.; Tognon, M.; Contini, C. SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants. Viruses 2021, 13, 1687. https://doi.org/10.3390/v13091687
Rotondo JC, Martini F, Maritati M, Mazziotta C, Di Mauro G, Lanzillotti C, Barp N, Gallerani A, Tognon M, Contini C. SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants. Viruses. 2021; 13(9):1687. https://doi.org/10.3390/v13091687
Chicago/Turabian StyleRotondo, John Charles, Fernanda Martini, Martina Maritati, Chiara Mazziotta, Giulia Di Mauro, Carmen Lanzillotti, Nicole Barp, Altea Gallerani, Mauro Tognon, and Carlo Contini. 2021. "SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants" Viruses 13, no. 9: 1687. https://doi.org/10.3390/v13091687